Vice president at ANI Pharmaceuticals Inc. (NASDAQ:ANIP) G. James Marken recently reported having sold 5,000 shares of common stock, at a weighted average Price of $34.28 per share. Following this transaction, Mr. Marken holds directly 46,568 at this $404.43 Million Market Cap company.
Over the course of this year, the company has witnessed other insider transactions, apart from Mr. Marken’s. During Q1, Director Tracy Marshbanks sold 47,125 shares, at prices ranging from $ 31.06 to $ 33.83 per share, and during the last reported quarter, he sold another 1,381 shares, at a price of $ 30.02 per share. Moreover, Large Shareholder Lp Ii Partners Venture Meridian sold 256,908 shares during March, 2014, at prices ranging from $ 31.05 to $ 33.83 per share.
Additionally, two big hedge funds have started investing at ANI Pharmaceuticals Inc (NASDAQ:ANIP) over the last reported quarter. Israel Englander’s Millennium Management holds 456,223 shares at the company, worth $14 million, and accounting for 0.04% of its Equity Portfolio. James E. Flynn’s Deerfield Management has also engaged in activity, and currently owns 371,572 shares, worth above $11 million, which represents 0.47% of the fund’s Equity Portfolio.
Disclosure: None.
Suggested Reading:
The 13 Most Expensive Headphones in the World to Represent
4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays
